GGrantIndex
← Leaderboards

Juan Carlos Ramos

University Of Miami School Of Medicine

$5,743,042
Attributed
$7,734,421
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200824
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$8,222,849 · 6

By mechanism

R42$2,987,068 · 2
R01$2,458,260 · 2
U01$2,289,093 · 1
U54$488,428 · 1

Top collaborators

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsMalignant NeoplasmsAreaAdultFloridaCellsUnited StatesViralUniversitiesSiteInfectionTherapeutic TargetHuman T-Lymphotropic Virus 1ZidovudineDisease RemissionAdult T-Cell Leukemia/LymphomaChemotherapyApoptosisProteinsBiologicalCytotoxic T-LymphocytesResponseT-LymphocyteCancer Center

Grant awards (18)

Human T Cell Lymphotropic Virus Vaccine Development$999,969
R42 · FY2024 · CA
STING Activators as Therapy for Cancer$993,879
R42 · FY2023 · CA
STING Activators as Therapy for Cancer$993,220
R42 · FY2022 · CA
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies$488,428
U54 · FY2022 · CA · contact PI
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma$330,140
R01 · FY2022 · CA · contact PI
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma$345,307
R01 · FY2021 · CA · contact PI
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma$353,492
R01 · FY2020 · CA · contact PI
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma$350,594
R01 · FY2019 · CA · contact PI
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma$369,155
R01 · FY2018 · CA · contact PI
University of Miami Core Site$166,392
U01 · FY2014 · CA · contact PI
University of Miami Core Site$584,308
U01 · FY2013 · CA · contact PI
University of Miami Core Site$541,546
U01 · FY2012 · CA · contact PI
University of Miami Core Site$40,909
U01 · FY2012 · CA · contact PI
University of Miami Core Site$538,004
U01 · FY2011 · CA · contact PI
University of Miami Core Site$417,934
U01 · FY2010 · CA · contact PI
Targeting of EBV Latency in Burkitt's Lymphoma$236,524
R01 · FY2010 · CA · contact PI
Targeting of EBV Latency in Burkitt's Lymphoma$236,524
R01 · FY2009 · CA · contact PI
Targeting of EBV Latency in Burkitt's Lymphoma$236,524
R01 · FY2008 · CA · contact PI